Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Target-controlled vs manual propofol infusion with alfentanil for pediatric shared airway surgery
ChiCTR2300074066Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propofol and alfentanil in arrhythmogenic cardiomyopathy (ACM) (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: Maximum arterial carbon dioxide. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
propofolalfentanil
03
Conditions
arrhythmogenic cardiomyopathy (ACM)
Beyond the preview
Go deeper on ChiCTR2300074066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074066.